Skip to main content

Privium Fund Management B.V.

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1795097 AMSTERDAM, P7

Position in TSHA

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,354,509
+$541,416 QoQ
Shares Held
198,900
+9.3% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#86
of 208 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Privium Fund Management B.V. holds $162,489,015 across 32 Biotechnology names. TSHA ranks #24 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TSHA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,354,509 198,900
2026-03-31 $813,093 181,900
2025-12-31 $906,950 164,900
2025-09-30 $441,123 134,900
2025-06-30 $311,619 134,900
2025-03-31 $187,511 134,900
2024-12-31 $233,377 134,900
2024-09-30 $241,200 120,000
2024-06-30 $220,640 98,500